Li Chen
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Natural Antidiabetic Agents Studies
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 51
- Diabetes Treatment and Management 26
- Surgery 78
- Pancreatic function and diabetes 29
- Co-authors
- Ming Zhang (10 shared papers)Xiaoyan Lv (6 shared papers)Xinguo Hou (65 shared papers)Weiping Jia (4 shared papers)Zhongyan Shan (4 shared papers)Wenying Yang (4 shared papers)Zhiguang Zhou (4 shared papers)Jiapu Ge (4 shared papers)
- Journals
- Journal of Diabetes (11 papers)PLoS ONE (11 papers)Diabetes Metabolic Syndrome and Obesity (8 papers)Scientific Reports (8 papers)Frontiers in Pharmacology (8 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Li Chen
584 papers receiving 21.4k citations
Li Chen's Hit Papers
Peers
Comparison fields: 5 of 181
- Endocrinology, Diabetes and Metabolism 4.6k
- Nephrology 829
- Pharmacology 1.2k
- Molecular Biology 4.3k
- Cardiology and Cardiovascular Medicine 1.4k
Countries citing papers authored by Li Chen
This map shows the geographic impact of Li Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Chen more than expected).
Fields of papers citing papers by Li Chen
This network shows the impact of papers produced by Li Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Chen. The network helps show where Li Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 610 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence of Diabetes among Men and Women in China Hit paper breakdown → | 2010 | 2630 |
| 2 | The Characterization of High‐Fat Diet and Multiple Low‐Dose Streptozotocin Induced Type 2 Diabetes Rat Model Hit paper breakdown → | 2008 | 565 |
| 3 | Standards of medical care for type 2 diabetes in China 2019 Hit paper breakdown → | 2019 | 538 |
| 4 | 2014 | 467 | |
| 5 | Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease Hit paper breakdown → | 2012 | 438 |
| 6 | 2012 | 362 | |
| 7 | Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study) Hit paper breakdown → | 2020 | 297 |
| 8 | 2016 | 265 | |
| 9 | 2006 | 226 | |
| 10 | 2009 | 211 | |
| 11 | 2019 | 207 | |
| 12 | 2010 | 183 | |
| 13 | 1997 | 176 | |
| 14 | Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database Hit paper breakdown → | 2022 | 176 |
| 15 | 2019 | 173 | |
| 16 | 2007 | 164 | |
| 17 | 2013 | 164 | |
| 18 | 2012 | 163 | |
| 19 | Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal Hit paper breakdown → | 2022 | 159 |
| 20 | 2016 | 152 |
About Li Chen
Li Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Pharmacology, Molecular Biology and Physiology, having authored 610 papers that have together received 21.9k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (51 papers), Pancreatic function and diabetes (29 papers), Diabetes Treatment and Management (26 papers), Extracellular vesicles in disease (24 papers), Chronic Kidney Disease and Diabetes (21 papers), Birth, Development, and Health (19 papers), Adipose Tissue and Metabolism (17 papers) and Drug Transport and Resistance Mechanisms (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.6k citations), Nephrology (829 citations), Pharmacology (1.2k citations), Molecular Biology (4.3k citations) and Cardiology and Cardiovascular Medicine (1.4k citations). Li Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Ming Zhang, Xiaoyan Lv, Xinguo Hou, Weiping Jia, Zhongyan Shan, Wenying Yang, Zhiguang Zhou, Jiapu Ge, Qiuhe Ji and Haoming Tian. Their work appears in journals such as Journal of Diabetes, PLoS ONE, Diabetes Metabolic Syndrome and Obesity, Scientific Reports and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.